Anthony Yeung1, Alex Kiss2, Damien Gallagher1,3. 1. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. 2. Evaluative Clinical Sciences, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada. 3. Division of Geriatric Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Abstract
OBJECTIVES: Intensive control of hypertension has been reported to decrease risk of cognitive decline. However, the effect of this in older adults with hypertension and comorbid depression is not well understood. We aim to identify whether intensive control of systolic blood pressure (BP) is associated with reduced risk of Alzheimer's dementia (AD) in a clinical population. METHODS: Using data from the National Alzheimer's Coordinating Center, we conducted survival analyses in older adults with normal cognition at baseline and treated hypertension. We also examined those with comorbid depression, to determine if intensive control of systolic BP (≤120 mmHg) was associated with reduced risk of AD. RESULTS: In all older adults with treated hypertension (n = 4505), 298 (6.6%) developed AD during a median follow-up duration of 4.2 years. In the comorbid depression subgroup (n = 1327), 152 (11.5%) developed AD. Intensive control of systolic BP was not significantly associated with reduced risk of AD in the overall sample (HR 1.13, 95%, 0.79-1.64). However, in the comorbid depression subgroup, intensive control of systolic BP (≤120 mmHg) was associated with increased risk of AD (HR 1.49, 95%, 1.03-2.15) compared to standard control (121-139 mmHg). CONCLUSIONS: In a clinical population of older adults with hypertension and comorbid depression, we found that an intensive systolic BP target of ≤120 mmHg was associated with increased risk of AD. While these findings are preliminary, they suggest that a more cautious approach to hypertension treatment may be warranted in this vulnerable subgroup.
OBJECTIVES: Intensive control of hypertension has been reported to decrease risk of cognitive decline. However, the effect of this in older adults with hypertension and comorbid depression is not well understood. We aim to identify whether intensive control of systolic blood pressure (BP) is associated with reduced risk of Alzheimer's dementia (AD) in a clinical population. METHODS: Using data from the National Alzheimer's Coordinating Center, we conducted survival analyses in older adults with normal cognition at baseline and treated hypertension. We also examined those with comorbid depression, to determine if intensive control of systolic BP (≤120 mmHg) was associated with reduced risk of AD. RESULTS: In all older adults with treated hypertension (n = 4505), 298 (6.6%) developed AD during a median follow-up duration of 4.2 years. In the comorbid depression subgroup (n = 1327), 152 (11.5%) developed AD. Intensive control of systolic BP was not significantly associated with reduced risk of AD in the overall sample (HR 1.13, 95%, 0.79-1.64). However, in the comorbid depression subgroup, intensive control of systolic BP (≤120 mmHg) was associated with increased risk of AD (HR 1.49, 95%, 1.03-2.15) compared to standard control (121-139 mmHg). CONCLUSIONS: In a clinical population of older adults with hypertension and comorbid depression, we found that an intensive systolic BP target of ≤120 mmHg was associated with increased risk of AD. While these findings are preliminary, they suggest that a more cautious approach to hypertension treatment may be warranted in this vulnerable subgroup.
Authors: Arad Kodesh; Sven Sandin; Abraham Reichenberg; Anat Rotstein; Nancy L Pedersen; Malin Ericsson; Ida K Karlsson; Michael Davidson; Stephen Z Levine Journal: Am J Geriatr Psychiatry Date: 2019-05-29 Impact factor: 4.105
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: J Am Soc Hypertens Date: 2018-08
Authors: Yvette I Sheline; Tim West; Kevin Yarasheski; Robert Swarm; Mateusz S Jasielec; Jonathan R Fisher; Whitney D Ficker; Ping Yan; Chengjie Xiong; Christine Frederiksen; Monica V Grzelak; Robert Chott; Randall J Bateman; John C Morris; Mark A Mintun; Jin-Moo Lee; John R Cirrito Journal: Sci Transl Med Date: 2014-05-14 Impact factor: 17.956
Authors: Andreea M Rawlings; Stephen P Juraschek; Gerardo Heiss; Timothy Hughes; Michelle L Meyer; Elizabeth Selvin; A Richey Sharrett; B Gwen Windham; Rebecca F Gottesman Journal: Neurology Date: 2018-07-25 Impact factor: 9.910
Authors: Laura Heath; Shelly L Gray; Denise M Boudreau; Ken Thummel; Karen L Edwards; Stephanie M Fullerton; Paul K Crane; Eric B Larson Journal: J Am Geriatr Soc Date: 2018-09-17 Impact factor: 5.562
Authors: Shimaa A Heikal; Mohamed Salama; Yuliya Richard; Ahmed A Moustafa; Brian Lawlor Journal: Front Aging Neurosci Date: 2022-02-07 Impact factor: 5.750